European Commission Initiative on Breast Cancer. Annual Declaration of Interests (ADoI)

Transcription

1 European Commission Initiative on Breast Cancer Annual Declaration of Interests (ADoI) Name: Mireille BROEDERS [Please copy rows as needed for subsequent or parallel activities of the same nature] [If it is not clear to you under which category of the form to declare an interest, you can declare it under "Other"]. Nature of activities Period Entity Subject matter 1. Ownership or financial investments, including shares Companies or organisations in which the financial interest is placed [Relevant field of activity] 2. Membership of a managing body or equivalent structure - Name - Location - Nature: public, private, etc. Function of institution: Function of expert: Link to website of institution:

2 3. Membership of another scientific advisory body 06/ current National Evaluation Team for Breast Cancer Screening (NETB) Coordinated by Erasmusmc, Rotterdam, NL Function of body: The National Evaluation Team for Breast cancer screening (NETB) has been entrusted with the ongoing evaluation of the breast cancer screening programme. The NETB reports to the Centre for Population Screening at the National Institute for Health and the Environment (RIVM). Function of expert: Member of the NETB Link to website of body: - 12/2015 current External Advisory Board H2020 consortium BRIDGES Coordinated by Prof Devilée, Leiden University Medical Center, NL Function of body: External Advisory Board Function of expert : Member Link to website of body : 08/ current External Advisory Board H2020 consortium PAMMOTH Coordinated by Dr Manohar, University of Twente, Enschede, NL Function of body: External Advisory Board Function of expert : Member Link to website of body :

3 4. Employment 05/1994 current Radboud university medical center, Nijmegen, The Netherlands Currently associate professor at the Department for Health Evidence. My research focuses on establishing the impact of cancer screening programmes, in particular screening for breast cancer. I have a special interest in observational research designs that can be used in this field of research. As a long-standing member of the National Evaluation Team for Breast Cancer Screening, I am also involved with the evaluation of the long-term benefits and harms of the Dutch nation-wide breast screening programme. 11/2007 current Dutch Expert Centre for Screening (LRCB), Nijmegen, The Netherlands. The Dutch Expert Centre for Screening (LRCB) aims to ensure and continuously improve the quality of screening. We want to ensure a high quality level of screening programmes and continuously improve the performance of the professionals involved and the necessary equipment. For this, we periodically monitor the medical content by medical audits and perform quality control measurements of the imaging systems. 06/ /2004 EUREF - European Reference Organisation for Quality Assured Breast Screening and Diagnostic Services EUREF, the European Reference Organisation for Quality Assured Breast Screening and Diagnostic Services, is a pan European organisation, widely drawn from different Member States and is operated on a non-profit making basis. The goal of EUREF is to promote high quality mamma-care in Europe. EUREF commits itself to the development and dissemination of the European Guidelines, certification of breast services and mammography equipment, and training and will provide support and advice on such issues upon request.

4 5. Consultancy/Advisory 11/2007 current Member of working group Communication and expertise enhancement, Centre for Population Screening, National Institute for Health and the Environment (RIVM) The working group provides advice to the Centre for Population Screening, which manages and coordinates the national population screening programmes for cervical cancer, breast cancer and colorectal cancer. RIVM is also responsible for providing clear public information. They coordinate and direct population screening programmes on behalf of the Ministry of Health, Welfare and Sport (VWS). 6. Influence on definition of research priorities 7. Research grants and other funding 11/2007 current Dutch Expert Centre for Screening (LRCB), Nijmegen, The Netherlands. Grants obtained for research conducted by LRCB aims to improve the quality, safety, efficiency, and effectiveness of screening programmes. Innovative screening strategies should help optimize the screening programme by maximising the effectiveness of screening while minimising its harms. Information from LRCB s research helps the target population make more informed decisions on participation in screening. 05/ current Radboud university medical center, Nijmegen, The Netherlands Grants obtained for research conducted by Dr Broeders at the Department for Health Evidence focus on the evaluation of the long-term benefits and harms of screening for breast cancer. In particular, she aims to study whether moving from the current 'one-size-fits-all' screening policies to more individualised screening approaches can help optimise the efficacy of breast cancer screening, by maximising its life-sparing effect and minimising side effects. 8. Principal investigator or investigator Principal investigator of the PRISMA study (Personalised RISk-based MAmmography screening) 9. Intellectual property rights (IPR)

5 10. Other membership or affiliation - Name, Place -Type: public, private, etc. [Describe activity, function, website] 11. Interests of others [Describe activity, function] 12. Other - Name, Place -Type: public, private, etc. [Describe activity, function, website] I also declare on my honour that the information disclosed in this form is true and complete to the best of my knowledge. Should there be any change to the above information, I will promptly notify the responsible service of the Commission and complete a new DoI form including the changes. Done at: Nijmegen, The Netherlands Date: 11 January 2018 Signature: